- 1. Introduction and an overview of the evolution of the Pap smear to cervical cancer screening as it is today
- Evolution of the Pap smear to cervical cancer screening today
- 2. Anatomy, histology and function of the uterine cervix
- Function of the cervix
- Squamous epithelium
- The columnar epithelium of the endocervix
- Metaplastic change in the cervix and its physiological basis
- 3. Cervical cancer epidemiology and aetiology of cervical carcinoma
- Aetiology of cervical cancer
- Mechanisms of HPV and other risk factors in oncogenesis
- References
- 4. Pathogenesis of cervical cancer
- Risk of progression of CIN3 to invasive carcinoma
- Adenocarcinoma and adenocarcinoma in situ
- Clinical presentation, stages and treatment of cervical cancer
- References
- 5. The principles of screening and measurement of accuracy
- Distinguishing progressive from reversible lesions
- Potential risks of treatment of high-grade CIN
- Measurement of accuracy
- References
- 6. The effect of screening on incidence and mortality
- Screening interval, age group and birth cohort
- Importance of quality control on the effect of screening
- Detection of early-stage occult cancers
- References
- 7. Use of HPV tests in cervical cancer screening and the effect of vaccination
- Uses of HPV testing in triage of cervical cytology
- HPV primary screening
- References
- 8. Collecting and processing cellular samples from the cervix
- Processing cytology samples in the laboratory
- References
- 9a. Terminology and criteria for adequacy
- Criteria for adequacy of a cervical cytology sample
- Guidelines for reporting negative cytology
- Guidelines for reporting abnormal cytology
- Atypical and borderline changes
- References
- 9b. Normal cytology and benign reactive changes
- Organisms seen in cervical cytology
- Reactive cytological changes
- References
- 9c. Cytological abnormalities
- Squamous cell abnormalities of the cervix
- Atypical squamous cells of undetermined significance (ASC-US)
- High-grade squamous intraepithelial lesion (HSIL)
- Distinction between moderate and severe dyskaryosis
- Four major presentations of HSIL
- Atypical squamous cells cannot exclude HSIL (ASC-H)
- Squamous cell carcinoma (SCC)
- Glandular abnormalities of the cervix
- References
- 9d. Management of women with normal and abnormal cytology
- 10. Pitfalls in cervical cytology
- Potential false negatives
- Potential false positives
- Avoidance of over-reporting of atypical/borderline cytology
- References
- 11. Quality assurance, quality control and quality standards
- QA and QC of the complete cervical screening process
- Collecting, preparing and fixing the cellular samples
- Processing the sample in the laboratory
- Cytological screening
- Reporting the cytology
- External quality assurance (EQA) procedures
- References
- 12. Cytology in a multidisciplinary setting
- Cytology review at the MDT meeting
- HPV test results discussed at the MDT meeting
- Colposcopic findings discussed at the MDT meeting
- Cervical biopsies presented at MDT meetings
- Summary of patient management in a multidisciplinary setting
- References
Home » Courses » Cervical cytology » Virtual slides
Cervical cytology
Cervical cytology Virtual slides
| Title | Source | Description |
|---|---|---|
| ThinPrep - Negative | ||
| ThinPrep - Negative | ||
| ThinPrep - Negative | ||
| ThinPrep - Borderline Changes | ||
| ThinPrep - Mild Dyskaryosis | ||
| ThinPrep - Moderate Dyskaryosis | ||
| ThinPrep - Severe Dyskaryosis | ||
| ThinPrep - Glandular Neoplasia | ||
| Conventional PAP smear. Negative. | ||
| [Virtual slide coming soon] SurePath - ASC-US 1 | ||
| [Virtual slide coming soon] SurePath - ASC-US 2 | ||
| [Virtual slide coming soon] SurePath - HSIL 1 | ||
| [Virtual slide coming soon] SurePath - HSIL 2 | ||
| [Virtual slide coming soon] SurePath - HSIL 3 | ||
| [Virtual slide coming soon] SurePath - LSIL | ||
| [Virtual slide coming soon] SurePath - Normal 1 | ||
| [Virtual slide coming soon] SurePath - Normal 2 | ||
| [Virtual slide coming soon] SurePath - Normal 3 | ||
| [Virtual slide coming soon] SurePath - Normal Endocervical |
